J. Goldman & Co’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-26,780
| Closed | -$856K | – | 408 |
|
|
2022
Q2 | $856K | Sell |
26,780
-87,312
| -77% | -$2.79M | 0.04% | 181 |
|
|
2022
Q1 | $3.95M | Buy |
+114,092
| New | +$3.95M | 0.18% | 87 |
|
|
2019
Q2 | – | Sell |
-33,789
| Closed | -$1.79M | – | 270 |
|
|
2019
Q1 | $1.79M | Sell |
33,789
-55
| -0.2% | -$2.91K | 0.1% | 104 |
|
|
2018
Q4 | $1.39M | Buy |
+33,844
| New | +$1.39M | 0.11% | 111 |
|
|
2018
Q2 | – | Sell |
-17,500
| Closed | -$845K | – | 348 |
|
|
2018
Q1 | $845K | Buy |
+17,500
| New | +$845K | 0.04% | 172 |
|
|
2017
Q3 | – | Sell |
-58,600
| Closed | -$1.6M | – | 311 |
|
|
2017
Q2 | $1.6M | Buy |
+58,600
| New | +$1.6M | 0.09% | 116 |
|
|
2016
Q3 | – | Sell |
-62,100
| Closed | -$1.03M | – | 317 |
|
|
2016
Q2 | $1.03M | Buy |
+62,100
| New | +$1.03M | 0.05% | 137 |
|